Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Immunology | Neurology | Family Medicine
Disease Category: Postherpetic Neuralgia
Location: United States, CO
Clinical Trial Details
Research Study Summary
New Investigational Medication for Postherpetic Neuralgia (PHN/Shingles)
This is a 12 week treatment study to evaluate the efficacy of two doses of new medication compared to placebo in lowering pain intensity in patients with PHN. There is also a 9 month follow - up period for a total duration of 12 months.
Patient Inclusion Criteria:
- Ages 18-80
- Persistant PHN pain for a minimum of 9 months following the onset of a herpes zoster skin rash (shingles)
- Must be willing to wash out of chronic pain medication for the 12 week treatment period.
Patient Exclusion Criteria:
- Must not have any other neuropathic pain
To Learn more
Both Male and Female
Date Last Changed:
July 16, 2013
DISCLAIMER: CenterWatch does not conduct clinical research.
CenterWatch is a publishing company that posts clinical trials information on behalf of sponsor companies,
contract research organizations, clinical research sites and other interested parties. This information
is designed to help patients find clinical trials of interest and contact the research centers
conducting the trials.